Understanding how enzymes break down heme in biological systems
Heme Oxygenases: chemically complex enzymes found in diverse biological pathways
This study is exploring how certain enzymes break down heme, a component found in blood, to help us understand how they work and how they might be used to target harmful germs that need heme to survive.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project ID | NIH-11017778 on NIH RePORTER |
What this research studies
This research focuses on the detailed mechanisms of heme oxygenases, enzymes that degrade heme into non-heme iron and other products. By developing accurate models and utilizing new optical assays, the research aims to uncover how these enzymes insert oxygen atoms into heme substrates. This knowledge is crucial for selectively targeting heme oxygenases in various biological contexts, including their role in iron acquisition by pathogenic organisms. The study will involve advanced spectroscopic techniques to analyze enzyme activity and binding interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to iron metabolism or infections caused by bacteria that utilize heme.
Not a fit: Patients with unrelated health conditions or those not affected by iron metabolism issues or bacterial infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies targeting heme oxygenases, potentially improving treatments for diseases related to iron metabolism and bacterial infections.
How similar studies have performed: While the mechanisms of heme oxygenases are generally understood, this research aims to provide novel insights that have not been extensively tested in previous studies.
Where this research is happening
Burlington, United States
- University of Vermont & St Agric College — Burlington, United States (Active)
Researchers
- Principal investigator: Liptak, Matthew D — University of Vermont & St Agric College
- Study coordinator: Liptak, Matthew D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.